NASDAQ
68.56USD
-2.58 (-3.63%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
2.9B
P/E
—
EPS
—
Beta
3.22
52W range
29.95-118.84
Day range
67.20–71.57
Open
70.22
Prev close
71.14
Volume
552.4K
Avg volume
673.9K
Dividend
0.00
IPO
2024-06-12
https://www.newsfilecorp.com/release/306994/ROSEN-LEADING-INVESTOR-COUNSEL-Encourages-Microvast-Holdings-Inc.-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-MVST · 7/29/2026-0.80
https://www.newsfilecorp.com/release/307000/EMBC-DEADLINE-ROSEN-GLOBAL-INVESTOR-COUNSEL-Encourages-Embecta-Corp.-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-EMBC · 7/29/2026-1.00
https://www.newsfilecorp.com/release/306193/Lucid-Group-Inc.-LCID-Deadline-Approaching-Berger-Montague-Advises-Investors-of-Deadline-in-Securities-Fraud-Lawsuit · 7/23/2026-0.80
https://www.globenewswire.com/news-release/2026/07/22/3331189/0/en/GRAL-Court-Alert-GRAIL-Inc-Investors-Seeking-to-Recover-Losses-in-Securities-Fraud-Class-Action-are-Notified-to-Contact-BFA-Law-before-August-4-Deadline.html · 7/22/2026
https://www.newsfilecorp.com/release/305374/GRAIL-INC.-SECURITIES-FRAUD-NOTICE-Berger-Montague-Informs-GRAIL-Inc.-GRAL-Investors-of-a-Securities-Fraud-Lawsuit · 7/16/2026-1.00
https://www.newsfilecorp.com/release/304754/GRAL-UPCOMING-DEADLINE-Faruqi-Faruqi-LLP-Reminds-Grail-GRAL-Investors-of-Securities-Class-Action-Lawsuit-Deadline-on-August-4-2026 · 7/13/2026-1.00
https://www.globenewswire.com/news-release/2026/07/06/3322783/32716/en/Embecta-Corp-EMBC-Faces-Securities-Class-Action-Over-Alleged-Concealed-Material-Risks-to-Pen-Needle-Revenue-HBSS.html · 7/6/2026-0.50
https://www.globenewswire.com/news-release/2026/07/06/3322285/0/en/GRAL-Fraud-Notification-GRAIL-Inc-Sued-for-Securities-Fraud-After-Trial-Results-Spark-a-50-Stock-Drop-Investors-Notified-to-Contact-BFA-Law-by-August-4.html · 7/6/2026-1.00
https://www.newsfilecorp.com/release/303703/GRAIL-Inc.-GRAL-Securities-Fraud-Contact-Berger-Montague-to-Discuss-Your-Rights · 7/2/2026-1.00
https://www.globenewswire.com/news-release/2026/06/29/3319202/3080/en/Levi-Korsinsky-Reminds-Shareholders-of-a-Lead-Plaintiff-Deadline-of-August-4-2026-in-Grail-Inc-Lawsuit-GRAL.html · 6/29/2026-1.00
https://www.globenewswire.com/news-release/2026/06/25/3317241/32716/en/Embecta-Corp-EMBC-Faces-Securities-Class-Action-for-Allegedly-Concealing-Competitive-Threats-to-Pen-Needle-Business-Hagens-Berman.html · 6/25/2026-1.00
https://www.globenewswire.com/news-release/2026/06/23/3316395/32716/en/Prestige-Consumer-Healthcare-Inc-PBH-Clear-Eyes-and-Pillar5-Problems-Drive-Stock-Lower-Hagens-Berman-Investigating.html · 6/23/2026-1.00
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
